The Long Run with Luke Timmerman
Timmerman Report
"The Long Run"
Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.
Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.
Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Episodes
Mentioned books
Oct 27, 2022 • 1h 15min
Ep123: Tariq Kassum on Single-Cell Analysis for Drug Discovery
Tariq Kassum, CEO of Cambridge, Mass.-based Celsius Therapeutics, on using single cell technology for drug discovery.
Oct 11, 2022 • 1h
Ep122: Aetna Wun Trombley on Extracellular Protein Degraders
Aetna Wun Trombley, CEO of Lycia Therapeutics, on extracellular protein degraders.
Sep 26, 2022 • 1h 4min
Ep121: Samantha Truex on Going Upstream Against Severe Asthma
Samantha Truex, CEO of Upstream Bio, on a new approach to treating severe asthma and other inflammatory diseases.
Sep 7, 2022 • 1h 4min
Ep120: Tim Lu on Gene Circuits for Cell Therapy
Tim Lu, CEO of Senti Biosciences, on developing gene circuits for cell therapy.
Aug 22, 2022 • 1h 3min
Ep119: Jo Viney on Discovering Treatments for Autoimmune Disease
Jo Viney, CEO of Seismic Therapeutic, on discovering new treatments for autoimmune disease.
Aug 8, 2022 • 1h 8min
Ep118: Ivan Liachko on Assembling Accurate Genomes and Interactomes
Ivan Liachko, CEO of Seattle-based Phase Genomics, on assembling accurate genomes and interactomes. He also discusses immigrating from Ukraine as a child, and what brought him and his family to the US.
Jul 11, 2022 • 1h 1min
Ep117: Dr. Sanduk Ruit on Restoring Eyesight in the Developing World
Dr. Sanduk Ruit of the Tilganga Institute in Kathmandu on restoring eyesight with affordable cataract surgery for the developing world.
Jun 22, 2022 • 59min
Ep116: Ivana Magovcevic-Liebisch on Precision Neuroscience
Ivana Magovcevic-Liebisch, CEO of Vigil Neuroscience, on precision neuroscience drug development.
Jun 7, 2022 • 59min
Ep115: Rahul Singhvi on Reimagining Biotech Manufacturing
Rahul Singhvi, CEO of Resilience, on rethinking the model for manufacturing of advanced biologics, gene and cell therapies.
May 23, 2022 • 1h 7min
Ep114: Chris Gibson on Industrializing Drug Discovery
Chris Gibson, co-founder and CEO of Recursion, on using new tools to industrialize drug discovery.
